Novartis Fights Zometa Jaw Injury Verdict In 11th Circ.
By Carolina Bolado (November 18, 2014, 4:42 PM EST) -- Novartis Pharmaceuticals Corp. on Tuesday fought a $250,000 verdict in multidistrict litigation over injuries allegedly caused by the bone drug Zometa, arguing to the Eleventh Circuit that it should not be held liable when the prescribing doctor failed to read the medication's warning.
Martin Calhoun of Hollingsworth LLP told an Eleventh Circuit panel that plaintiff J. Hunter Chiles' failure-to-warn claims fail because his doctor repeatedly testified that he did not read the insert in the Zometa packaging that included warnings about the drug's potential to cause the bone disease osteonecrosis of the jaw.
"If the doctor said repeatedly that he didn't...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!